Amber Whybro has extensive experience in the clinical research industry. Amber is currently Vice President of Global Start Up Operations at ICON plc since September 2020. Previously, they held various roles at IQVIA, including Head of Planning and Strategy for Global Site Activation, Senior Director of Business Operations & Capabilities, Senior Director of Clinical Operations for the UK & Ireland, and Clinical Solutions Director. Before joining IQVIA, Amber worked as a Clinical Director at MDS Pharma Services and as a Clinical Research Manager at Quintiles.
Amber Whybro's education history includes an Executive Leadership Program at Saïd Business School, University of Oxford, which was completed in 2020. Prior to that, they obtained a Master of Medical Science (MMedSc) degree in Human Metabolism & Clinical Biochemistry from The University of Sheffield between 1994 and 1996. Amber also earned another MMedSc degree in Clinical Human Nutrition from the same institution from 1993 to 1994. Amber's undergraduate studies include a Bachelor of Science (BSc) degree in Anatomy and Cell Biology from The University of Sheffield, which they completed from 1990 to 1993.
This person is not in any offices